Drug taking - For better of for worse?

Psychologist

Volumn 21, Issue 11, 2008, Pages 924-927

  Parrott, Andy ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61649086146     PISSN: 09528229     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. www.swan.ac.uk/staff/academic/HumanSciences/parrottandrew/#d.en.3200
2. Parrott, A., Morinan, A., Moss, M. & Scholey, A. (2004), Understanding drugs and behaviour. Chichester: Wiley.
3. Andreasson, S., Allebeck, P., Engstrom, A. & Rydberg, U. (1987). Cannabis and schizophrenia. The Lancet, Dec 26; 2, 1483-1486.
4. Chassin, L., Presson, C.C., Sherman, S.J. & Kim, K. (2002). Long term psychological sequelae of smoking cessation and relapse. Health Psychology, 21, 438-443.
5. Cohen, R.S. (1998). The love drug. New York: Haworth Medical Press.
6. Cohen, S. & Lichtenstein, E. (1990). Perceived stress, quitting smoking, and smoking relapse. Health Psychology, 9, 466-478.
7. Curran, H.V., Rees, H., Hoare, T. et al. (2004). Empathy and aggression. Psychopharmacology, 173, 425-433.
8. Davison, D. & Parrott, A.C. (1997). Ecstasy in recreational users. Human Psychopharmacology, 12, 91-97.
9. Dumont, G.J. & Verkes, R.J. (2006). A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. Journal of Psychopharmacology, 20, 176-187.
10. Fisk, J.E., Montgomery, C., Wareing, M. & Murphy, P.N. (2005). Reasoning deficits in ecstasy polydrug users. Psychopharmacology, 181, 550-559.
11. Gouzoulis-Mayfrank, E., Daumann, J., Tuchenhagen, F. et al. (2000). Impaired cognitive performance in drug free recreational users. Journal of Neurology, Neurosurgery & Psychiatry, 68, 719-725.
12. Greer, G. & Tolbert, R. (1986). Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs, 18, 319-327.
13. Halpern, J.H., Pope, H.G., Sherwood, A.R. et al. (2004). Residual effects of 3,4-methyelenedioxymethamphetamine in individual with minimal exposure to other drugs. Drug & Alcohol Dependence, 75, 135-147.
14. Hassan, N.A., Gunaid, A.A., El Khally, F.M. & Murray-Lyon, I.M. (2002). The subjective effects of chewing Qat leaves in human volunteers. Annals of Saudi Medicine, 22, 34-37.
15. Heffernan, T.M., Ling, J., Parrott, A.C. et al. (2005). Self-rated everyday and prospective memory abilities of cigarette smokers and non-smokers: A web based study. Drug and Alcohol Dependency, 78, 235-241.
16. James, J.E. & Rogers, P.J. (2005). Effects of caffeine on performance and mood. Psychopharmacology, 182, 1-8.
17. Johnson, J.G., Cohen, P., Pine, D.S. et al. (2000). Association between cigarette smoking and anxiety disorders during adolescence and early childhood. Journal of the American Medical Association, 284, 2348-2351.
18. Liechti, M.E., Gamma, A. & Vollenweider, F.X. (2001). Gender differences in the subjective effects of MDMA. Psychopharmacology, 154, 161-168.
19. Lloyd, B. & Lucas, K. (1997). Smoking in adolescence. London: Routledge.
20. Morgan, M.J. (2000). Ecstasy (MDMA). Psychopharmacology, 152, 230-248.
21. Murphy, R.S. & Parrott, A.C. (2006). Smoking causes stress. British Psychological Society Annual Conference: website abstract.
22. Pacifici, R., Zuccaro, P., Farre, M. et al. (2002). Cell-mediated immune response in MDMA users after repeated dose administration. Annals of the New York Academy of Sciences, 965, 421-433.
23. Parrott, A.C. (1994). Individual differences in stress and arousal during cigarette smoking. Psychopharmacology, 115, 389-396.
24. Parrott, A.C. (1999). Does cigarette smoking cause stress? American Psychologist, 54, 817-820.
25. Parrott, A.C. (2001). Human psychopharmacology of Ecstasy (MDMA). Human Psychopharmacology, 16, 557-577.
26. Parrott, A.C. (2003). Cigarette-derived nicotine is not a medicine. World Journal of Biological Psychiatry, 4, 49-55.
27. Parrott, A.C. (2004). MDMA or Ecstasy: The neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology, 50, 329-335.
28. Parrott, A.C. (2006a). MDMA in humans: Factors which affect the neuropsychobiological profiles of recreational Ecstasy users, the integrative role of bio-energetic stress. Journal of Psychopharmacology, 20, 147-163.
29. Parrott, A.C. (2006b). Nicotine psychobiology. Psychopharmacology, 184, 567-576.
30. Parrott, A.C. (2007a). Drug related harm. Human Psychopharmacology, 22, 423-426.
31. Parrott, A.C. (2007b). The psychotherapeutic potential of MDMA: An evidence-based review. Psychopharmacology, 191, 181-193.
32. Parrott, A.C. (in press). Cortisol and MDMA. Neuropsychobiology.
33. Parrott, A.C., Buchanan, T., Scholey, A.B. et al. (2002). Ecstasy attributed problems reported by novice, moderate and heavy recreational users. Human Psychopharmacology, 17, 309-312.
34. Parrott, A.C. & Lasky, J. (1998). Ecstasy (MDMA) effects upon mood and cognition. Psychopharmacology, 139, 261-268.
35. Parrott, A.C., Morinan, A., Moss, M. & Scholey, A.B. (2004). Understanding drugs and behaviour. Chichester: Wiley.
36. Parrott, A.C., Rodgers, J., Buchanan, T. et al. (2006). Dancing hot on ecstasy. Human Psychopharmacology, 21, 285-298.
37. Reay, J.L., Hamilton, C., Kennedy, D. & Scholey, A.B. (2006). MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Journal of Psychopharmacology, 20, 385-388.
38. Rendell, P.G., Gray, T.J., Henry, J.D. & Tolan, A. (2007). Prospective memory impairment in 'ecstasy' (MDMA) users. Psychopharmacology Jul 10; [Epub ahead of print]
39. Rodgers, J. (2000). Cognitive performance amongst recreational users of 'ecstasy'. Psychopharmacology, 151, 19-24.
40. Rodgers, J., Buchanan, T., Pearson, C. et al. (2006). Differential experiences of the psychobiological sequelae of ecstasy use. Journal of Psychopharmacology, 20, 437-446.
41. Rodgers, J., Buchanan, T., Scholey, A.B. et al. (2003). Differential effects of Ecstasy and cannabis on self report of memory ability. Journal of Psychopharmacology, 17, 389-397.
42. Shewan, D. & Dalgarno, P. (2005). Evidence for controlled heroin use? British Journal of Health Psychology, 10, 33-48.
43. Topp, L., Hando, J., Dillon, P. et al. (1999). Ecstasy use in Australia. Drug and Alcohol Dependency, 55, 105-115.
44. Zakzanis, K.K. & Campbell, Z. (2006). Memory impairment in abstinent MDMA users and continued users. Neurology, 66, 740-741.